Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients

NCT01254708 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Study has been placed on hold due to unavailability of funding.

Conditions

Lung Transplant Recipient

Interventions

DRUG: Ambisome ®
DRUG: Regular standard of care medication

Sponsor

University Health Network, Toronto